FCAP NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

First Capital Inc · Financial Services · Banks - Regional

Open interactive chart View report data
Latest close 63.28 USD
4.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 13.4% above the Trend Line and sits at 81.4% of its 52-week range. The latest completed week returned 4.2%, after a -2.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: earnings are due in 82d.

Setup score 64 out of 100
Latest Close 63.28 USD 31 Jul 2026
1W Return 4.2% latest completed week
4W Return -2.2% short-term follow-through
12W Return 10.9% quarterly tape
Trend Breadth 63.5% 33 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • The trend backdrop is active with a 17-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.2% Latest completed week; four-week move -2.2%. Indicator stack 80/57 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 53/100 55 relevant articles in the latest sentiment read. Event risk 82d Next report is scheduled for 23 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 13.4% above the Trend Line and sits at 81.4% of its 52-week range. The latest completed week returned 4.2%, after a -2.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8412-week average 0.72

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.84Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.2% over four weeks, 10.9% over 12 weeks, and 84.5% over one year. The current trend has remained active for 17 consecutive weeks.

Performance by holding period

1W4.2%
4W-2.2%
12W10.9%
26W8.6%
52W84.5%
Active trend streak17 weeks
Active weeks in one year33
Trend breadth63.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.59Latest activity-pressure read.
Pressure change-50.1%Four-week change in activity pressure.
Leadership12.66Latest relative-leadership reading.
RS change-5.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength98/100Blend of value, momentum, and quality. Underlying universe rank 3; rank 1 is best.
Value95/100Relative valuation strength. Underlying universe rank 6; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth84/100Revenue and earnings growth. Underlying universe rank 17; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
11.0x
Price divided by trailing earnings.
Price / sales
3.0x
Market value relative to trailing revenue.
EV / EBITDA
2.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
43.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
77.3%
Gross profit retained from each unit of revenue.
Operating margin
33.0%
Operating profit retained from revenue.
Free-cash-flow margin
32.9%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.2%
Latest one-year revenue growth.
EPS growth
40.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.0%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
2.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-6.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 55 relevant articles.

13 positive · 37 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings82dNext report is scheduled for 23 Oct 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.8%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+13.8%Week of 29 May.
Worst week-8.0%Week of 6 Feb.
Latest week+4.2%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains6
Flat weeks0
Modest losses8
Sharp losses5
Recent vol5.2%13-week weekly-return volatility.
Base vol6.6%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew5.0% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape66/100

Trend, activity pressure, participation, and risk combine to a 66/100 tape read.

 Indicator analysis80/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 10/12.

Activity pressure 0.84; 3 reversal markers Factors89/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 38; Small Cap Core rank 20 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 55 relevant articles.

First Capital, Inc. Revenue Breakdown – NASDAQ:FCAP Insiders50/100

No recent insider transaction evidence is stored.

 Earnings82d

Next report is scheduled for 23 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202663.28 USD4.2%55.81 USD38.11 USD0.5912.6672.9KOn
24 Jul 202660.72 USD-0.9%55.62 USD37.92 USD0.739.4781.7KOn
17 Jul 202661.28 USD-1.1%55.57 USD37.75 USD1.019.3264.2KOn
10 Jul 202661.99 USD-4.2%55.72 USD37.56 USD1.076.4926.9KOn
3 Jul 202664.69 USD-2.1%55.80 USD37.35 USD1.1913.3839.9KOn
26 Jun 202666.11 USD4.9%55.31 USD37.13 USD1.2217.25103.1KOn
19 Jun 202663.00 USD-1.9%54.75 USD36.89 USD1.107.2120.1KOn
12 Jun 202664.19 USD-2.5%54.20 USD36.66 USD0.9712.2523.4KOn
5 Jun 202665.82 USD7.0%53.56 USD36.43 USD0.6917.8829.5KOn
29 May 202661.51 USD13.8%52.81 USD36.17 USD0.395.4830.6KOn
22 May 202654.05 USD0.2%52.17 USD35.92 USD0.13-4.8427.1KOn
15 May 202653.92 USD-5.5%51.78 USD35.72 USD0.01-4.3314.1KOn
8 May 202657.08 USD5.1%51.30 USD35.52 USD-0.010.6516.3KOn
1 May 202654.30 USD1.5%50.78 USD35.29 USD-0.110.6522.2KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.